Polygenic risk score for ACE-inhibitor-associated cough based on the discovery of new genetic loci.
Ghouse J, Tragante V, Muhammad A et al.
Publication Details
Comprehensive information about this research publication
Abstract
Summary of the research findings
Aims: To search for sequence variants associated with ACEi discontinuation and to test their association with ACEi-associated adverse drug reactions (ADRs).
33,959 European ancestry cases who discontinued ACEi, 44,041 European ancestry controls who continued ACEi treatment
Study Statistics
Key metrics and study information
AI-Generated Summary
AI-generated by DNAGENICSIndependent AI summary of health and genetic findings from the published study
Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.
AI Summary In Progress
Our AI-generated summary of this publication is being prepared. Please check back soon.